Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.
<h4>Background</h4>Recent studies show the importance of interactions between CD47 expressed on acute myeloid leukemia (AML) cells and the inhibitory immunoreceptor, signal regulatory protein-alpha (SIRPα) on macrophages. Although AML cells express SIRPα, its function has not been invest...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4130b2e000fb4e6db767bbaff246bd5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4130b2e000fb4e6db767bbaff246bd5c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4130b2e000fb4e6db767bbaff246bd5c2021-11-18T08:02:20ZEngagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.1932-620310.1371/journal.pone.0052143https://doaj.org/article/4130b2e000fb4e6db767bbaff246bd5c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23320069/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Recent studies show the importance of interactions between CD47 expressed on acute myeloid leukemia (AML) cells and the inhibitory immunoreceptor, signal regulatory protein-alpha (SIRPα) on macrophages. Although AML cells express SIRPα, its function has not been investigated in these cells. In this study we aimed to determine the role of the SIRPα in acute myeloid leukemia.<h4>Design and methods</h4>We analyzed the expression of SIRPα, both on mRNA and protein level in AML patients and we further investigated whether the expression of SIRPα on two low SIRPα expressing AML cell lines could be upregulated upon differentiation of the cells. We determined the effect of chimeric SIRPα expression on tumor cell growth and programmed cell death by its triggering with an agonistic antibody in these cells. Moreover, we examined the efficacy of agonistic antibody in combination with established antileukemic drugs.<h4>Results</h4>By microarray analysis of an extensive cohort of primary AML samples, we demonstrated that SIRPα is differentially expressed in AML subgroups and its expression level is dependent on differentiation stage, with high levels in FAB M4/M5 AML and low levels in FAB M0-M3. Interestingly, AML patients with high SIRPα expression had a poor prognosis. Our results also showed that SIRPα is upregulated upon differentiation of NB4 and Kasumi cells. In addition, triggering of SIRPα with an agonistic antibody in the cells stably expressing chimeric SIRPα, led to inhibition of growth and induction of programmed cell death. Finally, the SIRPα-derived signaling synergized with the activity of established antileukemic drugs.<h4>Conclusions</h4>Our data indicate that triggering of SIRPα has antileukemic effect and may function as a potential therapeutic target in AML.Mahban IrandoustJulian Alvarez ZarateIsabelle HubeekEllen M van BeekKarin SchornagelAart J F BroekhuizenMercan AkyuzArjan A van de LoosdrechtRuud DelwelPeter J ValkEdwin SonneveldPamela KearnsUrsula CreutzigDirk ReinhardtEveline S J M de BontEva A CoenenMarry M van den Heuvel-EibrinkC Michel ZwaanGertjan J L KaspersJacqueline CloosTimo K van den BergPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e52143 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mahban Irandoust Julian Alvarez Zarate Isabelle Hubeek Ellen M van Beek Karin Schornagel Aart J F Broekhuizen Mercan Akyuz Arjan A van de Loosdrecht Ruud Delwel Peter J Valk Edwin Sonneveld Pamela Kearns Ursula Creutzig Dirk Reinhardt Eveline S J M de Bont Eva A Coenen Marry M van den Heuvel-Eibrink C Michel Zwaan Gertjan J L Kaspers Jacqueline Cloos Timo K van den Berg Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
description |
<h4>Background</h4>Recent studies show the importance of interactions between CD47 expressed on acute myeloid leukemia (AML) cells and the inhibitory immunoreceptor, signal regulatory protein-alpha (SIRPα) on macrophages. Although AML cells express SIRPα, its function has not been investigated in these cells. In this study we aimed to determine the role of the SIRPα in acute myeloid leukemia.<h4>Design and methods</h4>We analyzed the expression of SIRPα, both on mRNA and protein level in AML patients and we further investigated whether the expression of SIRPα on two low SIRPα expressing AML cell lines could be upregulated upon differentiation of the cells. We determined the effect of chimeric SIRPα expression on tumor cell growth and programmed cell death by its triggering with an agonistic antibody in these cells. Moreover, we examined the efficacy of agonistic antibody in combination with established antileukemic drugs.<h4>Results</h4>By microarray analysis of an extensive cohort of primary AML samples, we demonstrated that SIRPα is differentially expressed in AML subgroups and its expression level is dependent on differentiation stage, with high levels in FAB M4/M5 AML and low levels in FAB M0-M3. Interestingly, AML patients with high SIRPα expression had a poor prognosis. Our results also showed that SIRPα is upregulated upon differentiation of NB4 and Kasumi cells. In addition, triggering of SIRPα with an agonistic antibody in the cells stably expressing chimeric SIRPα, led to inhibition of growth and induction of programmed cell death. Finally, the SIRPα-derived signaling synergized with the activity of established antileukemic drugs.<h4>Conclusions</h4>Our data indicate that triggering of SIRPα has antileukemic effect and may function as a potential therapeutic target in AML. |
format |
article |
author |
Mahban Irandoust Julian Alvarez Zarate Isabelle Hubeek Ellen M van Beek Karin Schornagel Aart J F Broekhuizen Mercan Akyuz Arjan A van de Loosdrecht Ruud Delwel Peter J Valk Edwin Sonneveld Pamela Kearns Ursula Creutzig Dirk Reinhardt Eveline S J M de Bont Eva A Coenen Marry M van den Heuvel-Eibrink C Michel Zwaan Gertjan J L Kaspers Jacqueline Cloos Timo K van den Berg |
author_facet |
Mahban Irandoust Julian Alvarez Zarate Isabelle Hubeek Ellen M van Beek Karin Schornagel Aart J F Broekhuizen Mercan Akyuz Arjan A van de Loosdrecht Ruud Delwel Peter J Valk Edwin Sonneveld Pamela Kearns Ursula Creutzig Dirk Reinhardt Eveline S J M de Bont Eva A Coenen Marry M van den Heuvel-Eibrink C Michel Zwaan Gertjan J L Kaspers Jacqueline Cloos Timo K van den Berg |
author_sort |
Mahban Irandoust |
title |
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
title_short |
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
title_full |
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
title_fullStr |
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
title_full_unstemmed |
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
title_sort |
engagement of sirpα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/4130b2e000fb4e6db767bbaff246bd5c |
work_keys_str_mv |
AT mahbanirandoust engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT julianalvarezzarate engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT isabellehubeek engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT ellenmvanbeek engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT karinschornagel engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT aartjfbroekhuizen engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT mercanakyuz engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT arjanavandeloosdrecht engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT ruuddelwel engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT peterjvalk engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT edwinsonneveld engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT pamelakearns engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT ursulacreutzig engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT dirkreinhardt engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT evelinesjmdebont engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT evaacoenen engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT marrymvandenheuveleibrink engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT cmichelzwaan engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT gertjanjlkaspers engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT jacquelinecloos engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells AT timokvandenberg engagementofsirpainhibitsgrowthandinducesprogrammedcelldeathinacutemyeloidleukemiacells |
_version_ |
1718422598373605376 |